GU Cancers 2018 | MRI-based prostate cancer diagnosis: economic and logistical considerations
The take-home message from the 2018 Genitourinary Cancers Symposium, in San Francisco, CA, on MRI for prostate cancer diagnosis was positive. However, this leaves us with a variety of questions. In this interview, filmed at the meeting, Mark Emberton, MD, FRCS, of University College London, London, UK, gives us a concise and comprehensive summary of the economic and logistical issues with the use of MRI for prostate cancer diagnosis, including accessibility and changes to the previously straightforward diagnostic pathway.
Get great new content delivered to your inboxSign up